Skip to main content

AtlassianAtlassian made AI-training metadata contribution mandatory for non-Enterprise tiers, retaining de-identified data up to 7 years

Effective August 17, 2026, Atlassian's updated data contribution policy made metadata contribution (statistical characteristics, content patterns, search query keywords, Rovo Chat conversations) mandatory and non-optional for Free, Standard, and Premium tier customers; only Enterprise-tier customers retain the ability to opt out, and that ability is lost if an org downgrades from Enterprise. Atlassian's own support documentation states de-identified and aggregated data may be retained for up to seven years, and its sub-processor list names OpenAI as an authorized processor despite Atlassian's stated zero-data-retention agreements with third-party LLM partners.

Scoring Impact

TopicDirectionRelevanceContribution
Corporate Transparency-againstsecondary-0.50
User Privacy-againstprimary-1.00
Overall incident score =-0.443

Score = avg(topic contributions) × significance (medium ×1) × confidence (0.59)

Evidence (2 signals)

Context Criticism Aug 18, 2026 reported

Trade press flagged 7-year retention period as under-disclosed relative to opt-out fine print

Coverage of Atlassian's data contribution policy noted the 7-year retention period for de-identified, aggregated data is documented but not prominently disclosed in customer-facing communications, and that OpenAI is listed as an authorized sub-processor despite Atlassian's zero-data-retention claims with LLM partners.

Confirms Policy Change Aug 17, 2026 verified

Atlassian's official data contribution policy makes metadata sharing mandatory for non-Enterprise tiers

Atlassian's own trust and support documentation confirms tiered data contribution settings: metadata contribution cannot be opted out on Free/Standard/Premium plans (only Enterprise customers can opt out, and lose that ability on downgrade), with de-identified and aggregated data retained for up to 7 years, effective August 17, 2026.

Related: Same Topics